About this page
Why Participate in a Clinical Trial
Clinical Trials in Canada
ClinicalTrials.gov Identifier: NCT03752892
Idiopathic pulmonary fibrosis (IPF) is a lung disease that limits the ability to breathe enough for a good workout. One way to improve the exercise training is to reduce the number of muscles being trained together. By training one leg at a time, the patient does not have to breathe as much allowing each leg a better workout. Our groundwork suggests it may work in patients with IPF. This study will help decide whether one-legged exercise training is better at improving a patient’s exercise endurance compared to the usual way of exercising with both legs at the same time.
Study Locations as of March 18, 2019: (Recruiting) West Park Healthcare Centre, Toronto, ON M6M 2J5
Molecular diagnosis of idiopathic interstitial pneumonias is an innovative way to potentially improve the diagnostic accuracy of surgical lung biopsies (SLBs), introducing molecular classifiers of idiopathic pulmonary fibrosis (IPF) vs. non-specific interstitial pneumonia (NSIP), the 2 main types of idiopathic interstitial pneumonias (IIPs).
ClinicalTrials.gov Identifier: NCT03836417
Study Locations as of May 15, 2019: (Recruiting) London Health Science Centre, London, ON N6A 5W9
ClinicalTrials.gov Identifier: NCT03142191
Study Locations as of June 11, 2019: (Recruiting) Kelowna & Respiratory Allergy Clinic, Kelowna, BC V1W 1V3; The Lung Centre Respiratory Clinic – Vancouver General Hospital Location, Vancouver, BC V5Z 1M9 (Not yet recruiting) Dr. Syed Anees Medicine Professional Corporation, Windsor, ON N8X 1T3
ClinicalTrials.gov Identifier: NCT03733444
Study Locations as of May 20, 2019: (Recruiting) Dr Anil Dhar Professional Medicine Corporation,
Windsor, ON N8W1L9
ClinicalTrials.gov Identifier: NCT03287414
Study Locations as of March 25, 2019: (Recruiting) Novartis Investigative Site, QC GIV 4G5
ClinicalTrials.gov Identifier: NCT03864328
Study locations as of September 3, 2019 (Enrolling soon)
CHUM Centre de Recherche, Montreal, Quebec – PI: Dr. Morisett
Queen Elizabeth II Health Science Center, Halifax, Nova Scotia – PI: Dr. Paul Hernandez
St. Joseph’s Healthcare Hamilton/McMaster University, Hamilton, Ontario – PI: Dr. Kolb
St. Paul’s Hospital, Vancouver, BC – PI: Dr. Christopher Ryerson
University of Alberta, Edmonton, AB – PI: Dr. Meena Kalluri
ClinicalTrials.gov Identifier: NCT03018756
Study Locations as of September 25, 2018: (Recruiting) Queen’s University, Kingston, ON
ClinicalTrials.gov Identifier: NCT02632123
Study Locations as of November 7, 2018: (Recruiting) London Health Science Centre, London, ON
ClinicalTrials.gov Identifier: NCT02551068
Study Locations as of May 23, 2019:
(Recruiting) UBC Okanagan Kelowna, BC; St. Paul’s Hospital, Vancouver, BC; University of Calgary, Calgary, AB; McMaster University, Hamilton, ON; Queen’s University, Kingston, ON; McGill University, Montreal, QC; Laval University, Quebec City, QC
The following studies are not recruiting participants – Active or Completed.
ClinicalTrials.gov Identifier: NCT02951429
Study Locations as of May 6, 2019: Active but not recruiting participants.
ClinicalTrials.gov Identifier: NCT03261037
Study Locations as of April 11, 2019: Active, but not recruiting participants.
ClinicalTrials.gov Identifier: NCT02802345
Study Locations as of January 11, 2019: Completed. Has results.
ClinicalTrials.gov Identifier: NCT01619085
Study Locations as of April 30, 2019: Active but not recruiting participants. Has results.
ClinicalTrials.gov Identifier: NCT01890265
Study Locations as of May 3, 2019: Completed.
The following studies are not recruiting participants – Active or Completed.
ClinicalTrials.gov Identifier: NCT02999178
Study Locations as of May 15, 2019: Active but not recruiting participants.
ClinicalTrials.gov Identifier: NCT03099187
Study Locations as of May 29, 2019: Active but not recruiting participants.
The following studies are not recruiting participants – Active org Completed.
ClinicalTrials.gov Identifier: NCT02597933
Study Locations as of December 7, 2018: Completed. Boehringer Ingelheim May 20, 2019 release results